Pular para o conteúdo

Interações medicamentosas

Eslicarbazepine + Mavacamten

Gravidade: Contraindicada

Eslicarbazepine and Mavacamten: contraindicated interaction.

Última atualização

Para profissionais de saúde — apenas referência. Esta página é um resumo breve, não é aconselhamento médico nem substitui a bula oficial ou o julgamento clínico. Verifique sempre antes de prescrever ou dispensar.

O conteúdo clínico desta página está disponível apenas em inglês.

Resumo

Eslicarbazepine inhibits CYP2C19 and induces CYP3A4, which changes mavacamten exposure in unpredictable ways. Raised exposure risks systolic dysfunction and heart failure, whereas lowered exposure reduces efficacy.

O que esta interação significa em palavras simples

Eslicarbazepine and Mavacamten are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two.

Eslicarbazepine belongs to Central Nervous System; Mavacamten belongs to Cardiovascular.

Nível de evidência: Moderate

Por que acontece

Eslicarbazepine inhibits CYP2C19 and induces CYP3A4, both of which contribute to mavacamten clearance.

O que fazer

Avoid the combination and choose an alternative antiseizure drug. If the pair has been used, monitor LVEF and clinical status closely.

O que perguntar ao farmacêutico

  • Is there an alternative to one of these two medicines for me?
  • If both are essential, who is monitoring me and how often?
  • Which symptoms mean I should stop and seek help straight away?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Para assinantes do Pro+

Desbloqueie a página completa

Crie uma conta e comece um teste do Pro+ para desbloquear a orientação completa de conduta para Eslicarbazepine e Mavacamten, as notas adicionais, os detalhes da evidência e o verificador de interações para uma prescrição completa.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Experimente o Pro+ grátis por 14 dias na web. Sem cartão.

Perguntas frequentes

Can I take Eslicarbazepine with Mavacamten?

MediHelp rates the interaction as contraindicated. Eslicarbazepine and Mavacamten are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two. Eslicarbazepine inhibits CYP2C19 and induces CYP3A4, which changes mavacamten exposure in unpredictable ways. Raised exposure risks systolic dysfunction and heart failure, whereas lowered exposure reduces efficacy.

How serious is the interaction between Eslicarbazepine and Mavacamten?

MediHelp rates it contraindicated, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination and choose an alternative antiseizure drug. If the pair has been used, monitor LVEF and clinical status closely.

What other medicines interact with Eslicarbazepine?

MediHelp also lists interactions of Eslicarbazepine with, for example, Rilpivirine, Artemether / lumefantrine, Avapritinib. The full list is on the Eslicarbazepine page.

Monografias completas, posologia e verificador de interações no app MediHelp

Abra a referência completa, verifique interações entre vários medicamentos e use as ferramentas de posologia no app MediHelp.

Explorar de A a Z · Interações medicamentosas

Baixar o app Entrar